Visitors gather at Novartis' booth during a trade expo in Shanghai. Novartis achieved a growth of 17 percent in China, the second-largest pharmaceutical market worldwide, last year, making it one of the fastest-growing drugmakers in the country. "And I expect that we'll grow further this year as we'll continue our efforts of doing clinical trials in China, introducing innovative therapies …
